Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors-Reference-Cited by-同舟云学术

Dichloro-Phenyl-Benzotriazoles: A New Selective Class of Human Respiratory Syncytial Virus Entry Inhibitors

Published:2019-04-16 Issue: Volume:7 Page:
ISSN:2296-2646
Container-title:Frontiers in Chemistry
language:
Short-container-title:Front. Chem.

Author:

Piras Sandra,Sanna Giuseppina,Carta Antonio,Corona Paola,Ibba Roberta,Loddo Roberta,Madeddu Silvia,Caria Paola,Aulic Suzana,Laurini Erik,Fermeglia Maurizio,Pricl Sabrina

Funder

Ministero dell'Istruzione, dell'Università e della Ricerca

Publisher

Frontiers Media SA

Subject

General Chemistry

Reference35 articles.

1. Molecular mechanism of respiratory syncytial virus fusion inhibitors;Battles;Nat. Chem. Biol.,2016

2. Benzotriazole: an overview on its versatile biological behaviour;Briguglio;Eur. J. Med. Chem,2015

3. Triggering the measles virus membrane fusion machinery;Brindley;Proc. Natl. Acad. Sci. U.S.A,2012

4. RhoA-derived peptide dimers share mechanistic properties with other polyanionic inhibitors of respiratory syncytial virus (RSV), including disruption of viral attachment and dependence on RSV G;Budge;J. Virol,2004

5. Palivizumab in the prophylaxis of respiratory syncytial virus infection;Cardenas;Expert Rev. Anti-Infect. Ther,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Progress toward the Discovery of Small Molecules as Novel Anti-Respiratory Syncytial Virus Agents;Journal of Medicinal Chemistry;2024-07-06

2. Main and by-processes at 1-(2-nitroaryl)-1H-benzotriazole reduction;From Chemistry Towards Technology Step-By-Step;2024-03-23

3. Main and by-processes at 1-(2-nitroaryl)-1H-benzotriazole reduction;From Chemistry Towards Technology Step-By-Step;2024-03-23

4. Inhibition of respiratory syncytial virus by Daclatasvir and its derivatives: synthesis of computational derivatives as a new drug development;Journal of Biomolecular Structure and Dynamics;2024-01-13

5. Potentiality of bioactive compounds as inhibitor of M protein and F protein function of human respiratory syncytial virus;In Silico Pharmacology;2023-12-24